Stock Chart

CLLS

$1.43 +2.14%
Score: 49.1 HOLD
Pro
Screener
Vol: 0.23x (vs SPY: 0.2x | vs QQQ: 0.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
No qualifying chart pattern in the trailing 60 sessions — we only flag setups that pass our quality gate.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About CLLS - Cellectis S.A. American Depositary Shares

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Key Statistics

Market Cap $141M

This CLLS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track CLLS's price movements with trendlines, gamma walls, and key support/resistance levels.